Stargazer Pharmaceutcials Inc.

https://www.stargazerpharmaceuticals.com

Stargazer Pharmaceuticals, Inc., is a Boston-based biopharmaceutical drug development company launched in 2018 with a focus on rare diseases of the eye, and an initial focus on Stargardt Disease. *

	Start	2018-01-01 established
	Industry	ophthalmic
	Industry 2	drug development

	Region	Boston, MA
	Country	United States (USA)
	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Novo Holdings A/S. (11/9/20). "Press Release: Novo Ventures-incubated Rare Disease Company, Stargazer Pharmaceuticals, Enters Ph2 Development and Announces $57m Series A Financing". Boston, MA.

		Record changed: 2020-11-11

Picture [iito] Plain Stupid Simple 650x80px

More documents for Stargazer Pharmaceutcials Inc.

[1] Novo Holdings A/S. (11/9/20). "Press Release: Novo Ventures-incubated Rare Disease Company, Stargazer Pharmaceuticals, Enters Ph2 Development and Announces $57m Series A Financing". Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]